baber/WOPTO huggingface dataset:
Patent CA-3111600-A1 (CA)
Inventor: REYNOLDS MICHAEL
IPC: G07F11/38
Filed: 2019-09-19
Abstract: A system and method for producing a supply cabinet system configured to dispense a plurality of items. The method includes determining, for each of a plurality of item types, a number of units of the item type capable of being contained within each of a plurality of dimensional variations of each of a plurality of storage module types. A storage module configuration is selected to contain a target number of the items of each of the item types. Each selected storage module configuration corresponds to a dimensional variation of one of the storage module types. A rack arrangement to hold the selected storage module configurations is determined. The supply cabinet system may then be assembled using a set of storage modules corresponding to the selected storage module configurations and a set of rack members corresponding to the rack arrangement.
Patent CA-3112238-A1 (CA)
Title: Glute press exercise machine
Inventor: MEREDITH JEFFREY O
IPC: A63B23/04
Filed: 2019-09-17
Abstract: A glute press exercise machine including: a four-bar linkage connected to a stationary frame; a rotatable back support connected to the four-bar linkage; a seat connected to the four-bar linkage; and a foot support connected to the stationary frame. A lower portion of the back support extends below the user's hips to support the users hips during a glute press exercise. This lower portion supports at least 10% of the user's weight. In operation, the seat rotates downwardly away from the user's hips during a glute press exercise and then rotates upwardly again to contact the user's bottom between every repetition of the glute press exercise. The four-bar linkage is pivotally connected to the stationary frame at a location near ground level. The foot support is positioned below 25cm from the ground and extends forwardly beyond the front of the stationary frame.
Patent CA-3112301-A1 (CA)
Title: Granulation d'un edulcorant a base de stevia
Inventor: PURKAYASTHA SIDDHARTHA
IPC: A23L27/00
Filed: 2019-09-13
Abstract: L'invention concerne un procédé pour fabriquer un édulcorant granulé à base de stévia. L'édulcorant obtenu présente un niveau de solubilité avantageusement élevé.
Patent CA-3113719-A1 (CA)
Inventor: GOUDREAULT CLAUDE
IPC: G06F1/20
Filed: 2021-03-31
Abstract: A modular enclosure for housing various computing devices is provided. The modular enclosure includes a platform and a housing module mounted on the base module.  The housing module has lateral sides, a front side, a rear side and a roof defining an interior volume for receiving the various computing devices and fan cassettes. Each fan cassette is provided with its own controller which is configured to adjust the rotational speed of the fan based on the power consumption of the one or more computing devices. When connected in a cluster, the fan cassettes provide a N+1 redundancy, wherein each cassette as an adjacent fan cassette configured as an active backup. The fan cassettes of a cluster communicate via a communication bus. The fan cassettes may include dampers to redirect air drawn from the computing devices back toward them in cold whether conditions, or toward the outdoors, in hot weather conditions.
Patent CA-3113820-A1 (CA)
Inventor: GRANVILLE DAVID J
IPC: A61K31/7088
Filed: 2019-09-24
Abstract: In one aspect, methods for treating inflammatory skin conditions, such as atopic dermatitis and psoriasis, are provided. In another aspect, methods for promoting skin wound healing are provided. In a further aspect, methods for treating skin wounds, such as thermal and pressure injury are provided. In the methods, the activity of Granzyme K is reduced.
Patent CA-3114147-A1 (CA)
Inventor: GAO JINHENG
IPC: C07D487/14
Filed: 2019-09-26
Abstract: Disclosed is a compound as a fibroblast growth factor receptor 4 (FGFR4) inhibitor (as shown in formula (I)), and a pharmaceutical composition thereof and a preparation method therefor, as well as the use of same in the treatment of FGFR4-mediated diseases. The above-mentioned compounds act by participating in a number of processes, such as regulating cell proliferation, apoptosis, migration, neovascularization. <img file="dest_path_image002.jpg" he="51.06" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="60.06"/>
Patent CA-3114659-A1 (CA)
Title: Fault control for a wind farm with prioritization of the external setpoint-value specifications
Inventor: BROMBACH JOHANNES
IPC: H02J3/38
Filed: 2019-10-14
Abstract: The invention relates to a method for controlling a wind farm operated by means of a wind farm control unit, which wind farm comprises a plurality of wind turbines having wind turbine controllers, which wind turbines are connected to one another by means of a common wind farm grid, which is connected to an electrical supply grid of a grid operator by means of a wind farm transformer, comprising the steps: receiving at least one fault bit at the wind farm control unit, in particular at least one fault bit of the network operator; deactivating all external setpoint-value specifications at the wind farm control unit, except for those of the network operator, after the receipt of the fault bit; activating fault control implemented in the wind farm control unit after all external setpoint-value specifications except for those of the network operator have been successfully deactivated.
Patent CA-3117112-A1 (CA)
Inventor: GARCIA JOE G N
IPC: G01N33/68
Filed: 2019-10-31
Abstract: The present disclosure is directed to methods (e.g., in vitro methods) for use of nicotinamide phosphoribosyltransferase (NAMPT) as a biomarker in radiation-induced lung injury (RILI). Provided herein is an in vitro method for the diagnosis, prognosis, and/or monitoring of RILI in a human subject by providing a tissue or plasma sample from the subject and detecting the level of NAMPT therein, wherein a higher level of NAMPT in the tissue or plasma sample from the subject compared to a healthy control or a reference value is indicative for the presence of RILI in the subject. Further provided herein is a method of detecting NAMPT in a human subject by obtaining a biological sample from the subject, detecting the presence of NAMPT in the sample by contacting the sample with a capture agent that specifically binds NAMPT, and detecting binding between NAMPT and the capture agent.
Patent CA-3118412-A1 (CA)
Inventor: JIANG CHENGYU
IPC: A61P37/00
Filed: 2019-11-01
Abstract: Provided are a cell-penetrating peptide based on influenza virus M2 protein and a method for preparing and transforming same. Further provided are a conjugate containing the cell-penetrating peptide, a fusion protein and a composition, wherein the cell-penetrating peptide can be used for penetrating cells, introducing a molecule into cells and treating diseases.
Patent CA-3119348-A1 (CA)
Inventor: GUPTA RAM
IPC: B01F7/00
Filed: 2019-11-12
Abstract: An activated carbon powder comprising activated carbon particles that comprise D-band carbon corresponding to a sp3 hybridized disordered carbon phase and G-band carbon corresponding to a sp2 hybridized graphitic phase at a controlled proportion. Additionally, the activated carbon particles comprise nitrogen at an amount that is in a range of about 0.3 atomic % to about 1.8 atomic % of the activated carbon particles, wherein at least some of the nitrogen atoms are substituted for carbon atoms in the crystal lattice structure of the G-band carbon. Also, the carbon particles have a surface area that is in a range of about 900 m2/g to about 2,500 m2/g, an average pore width in a range of about 1 nm to about 4 nm, a microporous surface area in a range of about 300 m2/g to about 1,350 m2/g, and a cumulative surface area of pores with a hydraulic radius in a range of 0.285 nm to 1.30 nm that is in a range of about 1,000 m2/g to about 3,000 m2/g.
Patent CA-3119993-A1 (CA)
Inventor: OWEN DAVID JAMES
IPC: A61K31/502
Filed: 2019-11-20
Abstract: Provided herein are dendrimers comprising: a core unit, five generations of building units which are lysine residues or analogues thereof, first terminal groups comprising a residue of a camptothecin active covalently attached to a diglycolyl linker group, and second terminal groups comprising a PEG group. Also provided herein are pharmaceutical compositions comprising the dendrimer, and methods and uses of the dendrimers in therapy of disorders such as cancers. Processes for making the dendrimers and intermediates are also provided.
Patent CA-3120255-A1 (CA)
Inventor: VERHAMME PETER
IPC: A61K38/48
Filed: 2019-11-18
Abstract: La présente invention concerne l'utilisation d'ancrod pour la prophylaxie de l'endocardite ou le traitement de l'endocardite, en particulier pour le traitement de l'endocardite induite par une lésion. Selon la présente invention, de l'ancrod est de préférence administré par injection intraveineuse, perfusion intraveineuse, injection intramusculaire, injection sous-cutanée, injection intra-péritonéale, ou des combinaisons de ces méthodes. La présente invention concerne également des compositions pharmaceutiques, en particulier des solutions ou dispersions aqueuses d'ancrod destinées à la prophylaxie de l'endocardite ou au traitement de cette dernière.
Patent CA-3120695-A1 (CA)
Inventor: DUGGAL ROHIT
IPC: C12N5/0783
Filed: 2019-07-08
Abstract: La présente invention concerne du sang de cordon ombilical ou des cellules NK du sang périphérique qui sont préparés à partir de cellules mononucléaires de sang total sans avoir besoin d'isoler de cellules souches hématopoïétiques CD34+ ou de cellules NK et sans avoir besoin d'une couche d'alimentation. De manière avantageuse, les procédés de l'invention utilisent un procédé d'enrichissement qui utilise des anticorps agonistes anti-CD16, des anticorps anti-CD3 et N-803. De plus, les procédés envisagés sont appropriés pour une adaptation dans un processus de production entièrement automatisé (GMP dans une boîte).
Patent CA-3121168-A1 (CA)
Title: Heterodimeric tetravalency and specificity antibody compositions and uses thereof
Inventor: SANTICH BRIAN
IPC: C07K16/28
Filed: 2019-11-29
Abstract: The present disclosure relates generally to immunoglobulin-related compositions (e.g., heterodimeric trivalent/tetravalent multispecific antibodies) that specifically bind to three or four distinct target antigens. The immunoglobulin-related compositions described herein are useful in methods for detecting and treating cancer in a subject in need thereof.
Patent CA-3122305-A1 (CA)
Title: Clinic physical design and layout
Inventor: KADRI ALBERT
IPC: E04H3/08
Filed: 2020-01-24
Abstract: A medical clinic layout including a waiting room, reception area, modular clinic pods, patient exam rooms, physician workspace, pharmacy, laboratory, urgent care, imagingetc. optimizing the medical clinic layout's efficiency. These components are specifically fashioned to work synergistically to increase the efficiency of healthcare delivery and improve health outcomes, while also moving away from provider-centered care to patient-centered care.
Patent CA-3122497-A1 (CA)
Title: Pellet grills
Inventor: DONNELLY BRIAN C
IPC: F23B50/12
Filed: 2019-11-15
Abstract: Pellet grills and associated methods of operation are disclosed. An example pellet grill includes a one or more processors configured to detect an improper shutdown of a control system of the pellet grill. The one or more processors are further configured to generate a notification in response to the control system regaining power following detection of the improper shutdown, the notification indicating that the control system was improperly shutdown. The one or more processors are further configured to cause the notification to be presented at a user interface of the pellet grill.
Patent CA-3123534-A1 (CA)
Inventor: ARATANI MASATOSHI
IPC: C21D9/08
Filed: 2019-09-18
Abstract: Provided is an electric resistance welded steel pipe in which, despite a carbon content of 0.40% or more, quenching cracks do not occur and which also has excellent fatigue strength. The electric resistance welded steel pipe has a component composition consisting of, in mass%, C: 0.40-0.55%, Si: 0.10-1.0%, Mn: 0.10-2.0%, P: 0.10% or less, S: 0.010% or less, Al: 0.010-0.100%, Cr: 0.05-0.30%, Ti: 0.010-0.050%, B: 0.0005-0.0030%, Ca: 0.0001-0.0050%, and N: 0.0005-0.0050%, the balance being Fe and unavoidable impurities, and the outer surface and the inner surface have ferrite decarburized layers of 20-50 µm depth from the surface.
Patent CA-3124757-A1 (CA)
Inventor: MIZUTANI TSUYOSHI
IPC: C07D207/06
Filed: 2019-12-27
Abstract: L'invention porte sur une nouvelle nanoparticule ; un agent de contraste pour une imagerie par résonance magnétique la comprenant, et un composé ligand zwittérionique utilisé pour la production de la nanoparticule. L'agent de contraste pour IRM selon la présente invention peut être utilisé de manière appropriée en tant qu'agent de contraste pour IRM dans le domaine médical. La nanoparticule et le composé ligand zwittérionique selon la présente invention peuvent être utilisés dans diverses compositions pharmaceutiques, etc, notamment comme agent de contraste pour IRM, et peuvent être largement utilisés dans, par exemple, divers procédés de diagnostic et réactifs de test dans les domaines de la pharmacie, de la biotechnologie, etc.
Patent CA-3124982-A1 (CA)
Title: Utility model patent specification for "zygomatic implant with partially interrupted threaded portion"
Inventor: THOME GENINHO
IPC: A61C8/00
Filed: 2019-04-05
Abstract: The present utility model pertains to the field of odontological treatment components. It comprises: an implant (10) made up of an elongated cylindrical body (11); a conical apical region (12) covered with screw threads (121) and provided with at least three helical chambers (13) and a hemispherical end (14); and a cervical region defined by a smooth cervical surface (15), the elongated cylindrical body (11) comprising at least one longitudinal strip (112) with a substantially smooth surface, said smooth longitudinal strip (112) being located on the cervical portion of the zygomatic implant (10); the connection between the screw threads (111) and the smooth longitudinal strip (112) is made by a transitional curvature (113), and the smooth longitudinal strip (112) is aligned with one of the flat faces of the internal portion with hexagonal cross-section (18) of the prosthetic interface of the implant (10).
Patent CA-3125537-A1 (CA)
Inventor: ARORA AMIT
IPC: G06F9/50
Filed: 2019-12-17
Abstract: La présente invention concerne des procédés, des systèmes et un appareil, comprenant des programmes d'ordinateur codés sur un support de stockage informatique, pour déterminer une disponibilité d'un service de réseau. Dans certains modes de réalisation, une demande indiquant un emplacement et un niveau de service de communication est reçue. Un premier sous-ensemble de fournisseurs de service ou de technologies de communication est déterminé sur la base de sorties générées par de multiples premiers modèles d'apprentissage machine, chacun instruit pour prédire une disponibilité de service pour différents fournisseurs de service ou technologies de communication. Un second sous-ensemble est sélectionné à partir du premier sous-ensemble sur la base de sorties générées par de multiples deuxièmes modèles d'apprentissage machine, instruits pour prédire la disponibilité de différents niveaux de service de communication pour différents fournisseurs de service ou technologies de communication. Au moins un fournisseur de service ou une technologie de communication est sélectionné à partir du second sous-ensemble sur la base d'une sortie générée par un troisième modèle d'apprentissage machine. L'invention concerne également une réponse à la demande indiquant le fournisseur de service sélectionné ou la technologie de communication sélectionnée.
Patent CA-3129091-A1 (CA)
Title: Dehumidifier
Inventor: LIU FASHEN
IPC: F24F1/029
Filed: 2020-09-30
Abstract: This application discloses a dehumidifier including a water tank, a machine body and a position limiting structure. The water tank has a mounting opening facing upward, the machine body has an idle state in which the machine body is at least partially housed in the water tank through the mounting opening. The position limiting structure includes a stopper. The stopper is movable into and out of the mounting opening, and has a first position and a second position. At the first position, the stopper is in the mounting opening and located on a movement path of the machine body moving toward the water tank. At the second position, the stopper is positioned out of the mounting opening for the machine body to be accommodated in the water tank.
Patent CA-3129625-A1 (CA)
Inventor: REINHARD ROBERT
IPC: A01N47/20
Filed: 2020-02-11
Abstract: L'invention concerne des mélanges pesticides comprenant comme composés actifs 1) 1-[(1RS)-1,2-diméthylpropyl]-N-éthyl-5-méthyl-N-pyridazin-4-yl-1H-pyrazole-4-carboxamide et 2) au moins un autre composé B choisi parmi B.1) les inhibiteurs de la succinate déshydrogénase tels que définis dans la description ; B.2) des inhibiteurs de la protéine de liaison à l'oxystérol tels que définis dans la description ; B.3) des inhibiteurs du complexe III au niveau du site Qi choisi parmi : a) du florylpicoxamide, et b) du fénpicox-amide ; B.4) des strobilurines telles que définies dans la description ; B.5) des inhibiteurs de la C14-déméthylase dans la biosynthèse des stérols telles que définies dans la description ; B.6) des inhibiteurs de la division cellulaire et du cytosquelette tels que définis dans la description, B.7) d'autres composés de mode d'action inconnu tels que définis dans la description ; et B.8) N-[[2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophényl)-3-(trifluorométhyl) pyrrolidin-1-yl]phényl]méthyl]cyclopropanecarboxamide ; le composant 1) et le composant 2) sont présents dans un rapport pondéral de 1000:1 à 1:1000 ; des procédés et l'utilisation desdits mélanges pour lutter contre des nuisibles invertébrés tels que les insectes, les arachnides, les nématodes et/ou les champignons nuisibles dans et sur les plantes, et pour protéger lesdites plantes infestées par des organismes nuisibles et/ou des champignons nuisibles.
Patent CA-3130846-A1 (CA)
Title: Composes de catalyseur microporeux et leurs utilisations
Inventor: BEUTEL TILMAN W
IPC: C01B39/02
Filed: 2020-01-22
Abstract: La présente invention concerne des composés et des compositions de catalyseur mésoporeux ayant un ou plusieurs atomes du groupe 13. La présente invention concerne en outre des processus pour convertir des charges hydrocarbonées en petites oléfines. Dans un aspect, un composé catalyseur comprend une zéolite ayant un type structural choisi parmi MFI, MSE, MTW, Theta-One (TON), Terri erite (TER), ATI, ATS, ATO, BEA, BEC, BOG, BPH, CAN, CON, EMT, EON, EZT, FAU, GME, GON, IFR, ISV, ITN, IWR, IWW, LTL, MAZ, MEI, MOR, MOZ, OFF, OKO, OSI, SAF, SAO, SEW, SEE, SFO, SSF, SSY, et ETSI, ou une combinaison de ceux-ci, la zéolite ayant un rapport molaire silicium/aluminium (rapport Si/Al) d'environ 5 à environ 40. Dans un aspect, une composition de catalyseur comprend le composé catalyseur et un ou plusieurs métaux du groupe 13.
Patent CA-3131616-A1 (CA)
Inventor: KARL MOSHE
IPC: G06F16/906
Filed: 2021-09-22
Abstract: A system, computer readable medium and method for detecting anomalous activity based on a data distribution is disclosed. The system includes a processor, and a memory coupled to the processor. The memory stores computer executable instructions that, when executed by the processor, cause the processor to obtain a plurality of datapoints defining a data distribution. The processor classifies the plurality of datapoints as isolated or non-isolated datapoints, and clusters at least some of the non-isolated datapoints into at least one mode segment. A reference mode from the at least one mode segment is identified, and at least one outlier being either an isolated or non-isolated datapoint separated from the reference mode by a predetermined number of isolated datapoints representing a flat portion is identified. An action is initiated based on the identified at least one outlier.
Patent CA-3132911-A1 (CA)
Inventor: DUMONT Nicolas
IPC: B29C70/24
Filed: 2020-03-11
Abstract: The present disclosure relates to a process for manufacturing a product made of composite materials comprising areas with different functionalities from a knitted preform. The inventors have discovered that it is possible to knit a dry preform comprising areas of different composition and than to transform same by melting into a solid composite material comprising areas with different functionalities. By different functionality, it is possible to provide areas of different rigidity, areas of different abrasion resistance, and areas of different electrical conductivity or thermal conductivity, areas of different transparency.
Patent CA-3133445-A1 (CA)
Title: Systems and methods for automated fraud detection
Inventor: ZHANG YANJUN
IPC: G06F21/50
Filed: 2021-10-06
Abstract: Computer implemented methods and systems for automatically detecting whether transaction requests received at a computer system of an entity are fraud include receiving, at a machine learning model, inputs of historical and current transaction data, the model having been trained on the historical data including any fraud indications, determining and illustrating connections in a network graph including similarities between transactions in the new and historical transaction data based on overlap between values for the set of features for the transactions such that the links connecting the transactions in the nodes to show the overlap in features to define a relationship, the links further visually depicting which particular features from the set of features overlap in value between the transactions having the connections; and cluster the illustrated connections into defined groups and associate each cluster group as being either fraud transactions or non-fraudulent.
Patent CA-3134961-A1 (CA)
Inventor: CHAVAN ABHI
IPC: A61B17/00
Filed: 2020-04-09
Abstract: An insertion tool for creating a subcutaneous pocket and implanting a device in the pocket. The tool may include a cannula extending from a handle, a dissector tip disposed at a distal end of the cannula, and a rod. The cannula and dissector tip may create the pocket. The cannula may include a passage and an opening into the passage, and the cannula may be disposed in the passage and move along the passage between a retracted position and an extended position. The rod and the cannula may be configured such that, when the rod is at the retracted position, the cannula holds the device in the passage, and as the cannula moves from the extended position to the retracted position, the rod forces the device through the opening at the distal end of the cannula, at least partially out of the cannula, and at least partially into the pocket.
Patent CA-3135044-A1 (CA)
Inventor: MCCOMB SCOTT
IPC: C12N5/10
Filed: 2020-03-23
Abstract: The present disclosure relates to antigen-binding agents that specifically bind to epidermal growth factor receptor variant III (EGFRvIII). Antigen-binding agents of the present disclosure include antibodies and antigen-binding fragments thereof, chimeric antigen receptors (CARs) and bi-specific T-cell engagers (BiTE!), bispecific killer cell engagers (BiKEs) and trispecific killer cell engagers (TriKEs). Nucleic acid molecules and vectors expressing antibodies, antigen-binding fragments, CARs, BiTEs, BiKEs or TriKEs are also encompassed by the present disclosure. Immune cells engineered to express CARs, BiTEs, BiKEs or TriKEs may be used to specifically recognize and kill cells expressing EGFRvIII.